Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Healthy Participants 1

Interventions

Cyclophosphamide 62 Rituximab 47 fludarabine 35 fludarabine phosphate 27 obinutuzumab 17 Mycophenolic Acid 16 ibrutinib 15 Whole-Body Irradiation 15 Lenalidomide 15 Specimen Handling 14 Prednisone 14 venetoclax 13 pirtobrutinib 13 Etoposide 13 Doxorubicin 13 pembrolizumab 12 Tacrolimus 12 Magnetic Resonance Spectroscopy 11 Granulocyte Colony-Stimulating Factor 11 Filgrastim 11 Biopsy 11 Vincristine 10 Peripheral Blood Stem Cell Transplantation 10 Melphalan 10 X-Rays 9 Bendamustine Hydrochloride 9 polatuzumab vedotin 8 glofitamab 8 acalabrutinib 8 Immunotherapy, Adoptive 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Dextromethorphan × 1 year × Clear all

NCT06383338 2025-09-08

PEGASUS

Murdoch Childrens Research Institute

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡